Highlights

  • Iperionx (ASX:IPX) is developing a vertically integrated titanium Supply chain combining mineral production and advanced manufacturing.
  • The company completed a feasibility study for its Titan critical minerals project with supportive project economics.
  • Customer programmes across defence, automotive and industrial markets continue progressing alongside Manufacturing expansion.
  • Production scaling, project funding and commercialisation remain key areas for investors to monitor.

Titanium has become an important critical mineral due to its applications across aerospace, defence, automotive and advanced manufacturing industries. Iperionx (ASX:IPX) is seeking to establish a domestic United States titanium supply chain by combining mineral resources with proprietary manufacturing technology.

The company has progressed from a development-stage critical minerals Business towards commercial production activities, with customer programmes underway and manufacturing capacity expanding. The key focus for investors is whether Iperionx can successfully scale production while advancing its Titan project.

Iperionx (ASX:IPX) released its June 2026 Quarterly Report in July 2026, highlighting completion of a United States Government-supported definitive feasibility study for the Titan critical minerals project.

The feasibility study outlined an after-tax net present value of US$813 million based on an 8% discount rate, with an internal rate of return of 39.4% and an expected payback period of 3.6 years.

The study also outlined forecast free Cash Flow generation across an initial mine plan, supporting the company’s strategy of developing an integrated titanium supply chain.

Company Overview

Iperionx (ASX:IPX) operates across two interconnected areas: titanium manufacturing and critical minerals development.

At its South Boston, Virginia facility, the company uses its proprietary HAMR process to produce titanium alloy powder, including Ti-6Al-4V powder, alongside advanced powder metallurgy technologies for component manufacturing.

The company’s Titan project is a permitted United States critical minerals development opportunity with exposure to titanium, zircon and rare earth elements including dysprosium, terbium and yttrium.

Iperionx’s strategy is focused on moving beyond traditional mineral extraction by combining resource development with Downstream metal and component production.

Recent Developments

Manufacturing capability continued expanding during the June 2026 quarter.

A 300-tonne powder metallurgy press completed commissioning, increasing production capacity, while additional furnace infrastructure was installed to support future output growth.

The Virginia manufacturing Facility continued operating production activities, although maintenance requirements affected powder output during the period.

Customer programmes also advanced across multiple industries, including defence, automotive and industrial applications. The company progressed testing and development activities involving titanium components for customers such as Carver Pump, Ford and the United States Army.

Financial and Operational Position

Iperionx (ASX:IPX) reported cash of US$35.2 million as at 30 June 2026, alongside additional government reimbursements expected to be received.

The company subsequently completed an Equity raising in July 2026, strengthening its cash position to support manufacturing expansion and ongoing project development activities.

Government support remains an important component of the company’s strategy, including funding programmes linked to domestic critical mineral and defence supply chains.

Titanium powder production reached approximately 4.2 tonnes during March 2026, with the company targeting a significantly higher annual production rate as additional manufacturing capacity is commissioned.

What Investors May Watch Next

Scaling manufacturing output remains the key operational milestone for Iperionx (ASX:IPX). Investors may monitor whether the company achieves its targeted production levels as additional equipment becomes operational.

Customer conversion will also remain important, particularly whether defence and industrial testing programmes translate into repeat commercial orders.

The funding pathway for the Titan project following the feasibility study will be another major consideration, as development of the project requires significant capital investment.

Government reimbursement timing and continued support for domestic critical minerals initiatives will also influence progress.

Risks

Iperionx (ASX:IPX) remains in a scaling phase, creating execution risks around manufacturing expansion, commissioning activities and production consistency.

The company continues to depend on government programmes and policy support, which may be affected by changing priorities or funding conditions.

Development of the Titan project requires additional capital, and project Economics remain dependent on assumptions around costs, pricing and execution.

Customer programmes are still progressing through testing and early commercial stages, meaning future Demand levels remain uncertain.

Key Takeaways

Iperionx (ASX:IPX) is pursuing a differentiated critical minerals strategy by combining titanium resource development with advanced manufacturing capabilities.

The company has achieved several important milestones, including feasibility completion, customer engagement and manufacturing expansion. However, the next phase will depend on successfully scaling production, securing long-term customers and funding the Titan project.